Cardiovascular Disease, its Risk Factors and Treatment, and Age-related Macular Degeneration: Women’s Health Initiative Sight Exam Ancillary Study-Reference-Cited by-同舟云学术

Cardiovascular Disease, its Risk Factors and Treatment, and Age-related Macular Degeneration: Women’s Health Initiative Sight Exam Ancillary Study

Published:2007-03 Issue:3 Volume:143 Page:473-483.e2
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Klein Ronald,Deng Yingzi,Klein Barbara E.K.,Hyman Leslie,Seddon Johanna,Frank Robert N.,Wallace Robert B.,Hendrix Susan L.,Kuppermann Baruch D.,Langer Robert D.,Kuller Lewis,Brunner Robert,Johnson Karen C.,Thomas Asha M.,Haan Mary

Publisher

Elsevier BV

Subject

Ophthalmology

Reference50 articles.

1. Causes and prevalence of visual impairment among adults in the United States;Congdon;Arch Ophthalmol,2004

2. The epidemiology of age-related macular degeneration;Klein;Am J Ophthalmol,2004

3. Epidemiology of age-related macular degeneration;Seddon,2006

4. Hormone therapy and age-related macular degeneration: the Women’s Health Initiative Sight Exam Study;Haan;Arch Ophthalmol,2006

5. Design of the Women’s Health Initiative clinical trial and observational study: the Women’s Health Initiative Study Group;Control Clin Trials,1998

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration;Medicina;2024-05-15

2. Chorioretinal Atrophic Lesions Evolution in Patients with Quiescent Myopic Choroidal Neovascularization Followed for More Than 10 Years;Clinical Ophthalmology;2024-05

3. Obesity as a Risk Factor for the Ineffectiveness of Antiangiogenic Treatment of Neovascular Age-related Macular Degeneration;Ophthalmology in Russia;2024-03-31

4. Systemic Arterial Hypertension and Ophthalmohypertension as Independent Risk Factors for Poor Response to Antiangiogenic Therapy with Line 1 Drugs in Neovascular Age-related Macular Degeneration;Ophthalmology in Russia;2024-03-31

5. Nighttime Outdoor Artificial Light and Risk of Age-Related Macular Degeneration;JAMA Network Open;2024-01-16